Home » Topics » BioWorld Science

BioWorld Science
RSS

New hypoglycemic agents developed by Yissum and Hadasit researchers

June 7, 2004

Novel GAL3 antagonists and their use in depression and anxiety treatment

June 7, 2004

New bone resorption inhibitors targeting OCIF presented by Sankyo

June 7, 2004

Gilead claims new HIV integrase inhibitors

June 7, 2004

Losartan reduces lung injury in preclinical studies

June 7, 2004

SD-208 shows promise in models of pulmonary fibrosis

June 7, 2004

Cannabinoid receptor partial agonist with antihyperalgesic and antiallodynic effects in vivo

June 7, 2004

LL-37 demonstrates angiogenic activity in vitro

June 7, 2004

Strattera receives U.K. approval

June 7, 2004

Clofarabine NDA accepted for priority review

June 7, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...